Carson Advisory’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Carson Advisory's PFE Position: Q2 2026 in Review
Carson Advisory reduced its Pfizer (PFE) stake by 2% in Q2 2026, selling an estimated $4.87K and leaving 8,988 shares worth $216K. The position accounts for 0.1% of the portfolio, ranked #191.
Carson Advisory first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.4M in Q4 2021. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Carson Advisory held 8,988 shares of Pfizer worth $216K as of Q2 2026.
- Carson Advisory sold 186 Pfizer shares in Q2 2026, an estimated $4.87K.
- Pfizer made up 0.1% of Carson Advisory's portfolio in Q2 2026, its #191 holding.
- Carson Advisory first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
- Carson Advisory's Pfizer position peaked at $1.4M in Q4 2021.
- 2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Carson Advisory's 13F filing for Q2 2026, filed 11 Aug 2026.